1Mazzaferri EL,Jhiang SM. Long-time impact of initial surgical and medical therapy on papillary and follicular thyroid cancer [J]. Am J Med,1994,97(11) :418-428.
6Yang GC, Livolsi VA, Baloch ZW. Thyroid microcarcinoma: fine-needle aspiration diagnosis and histologic follow-up [ J]. Int J Surg Pathol,2002,10(2) :133-139.
7Shah JP, Loree TR, Dharker D, et al. Prognostic factors in differentiated carcinoma of the thyroid gland [J] . Am J Surg, 1992,164(12) :658-661.
8Sellers M, Beenken S, Blankenship A, et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer[J]. Am J Surg, 1992,164(12) : 578-581.
9Kim JM, Kim TY, Kim WB, et al. Lymphovascular invasion is associated with lateral cervical lymph node metastasis in papillary thyroid carcinoma[J]. Laryngoscope,2006,116(11) : 2081-2085.
4Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid turners: a commentary on the cdition[J ]. Cancer, 1989,63(3) :908.
5Stewart BW,Kleihues P. World Cancer Report[ M]. Lyon: IARC Press, 2003:26 - 52.
6[1]Hundahl S A,Fleming I D,Fremgen A M,et al.A national cancer data base report on 53856 cases of thyroid carcinoma treated in the U.S.,1985～1995.ancer,1998,83 (12):2638-2648.
7[2]Holzer S,Reiners C,Mann K,et al.Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996.Cancer,2000,89(1):192-201.
8[3]Brierly J D,Panzarella T,Tsang R W,et al.A comparison of different staging systems predictability of patient outcome.Cancer,1997,79 (12):2414-2423.
9[5]Kinder B K.Well differentiated thyroid cancer.Curr Opin Oncol,2003,15(1):71-77.
10[6]Cad Y B,Rossi R.An expanded view of risk-group definition in differentiated thyroid carcinoma.Surgery,1988,104(6):947-953.
1Ngan ES,Lang BH,Liu T,et al.A germline mutation(A339V)in thyroid transcription factor-1(TITF-1/NKX2.1)in patients with multinodular goiter and papillary thyroid carcinoma[J].J Natl Cancer Inst,2009,101(3):162-175.
2Cong SZ,Li K,Wu LS,et al.Compound scan technology of ultrasound in diagnosis of thyroid carcinoma[J].Chin J Med Imaging Technol,2006,22(8):1183-1184.
3Fiore E,Rago T,Provenzale MA,et al.Lower levels of TSH are associated to a lower risk of papillary thyroid cancer in patients with thyroid nodular disease:thyroid autonomy may play aprotective role[J].Endocr Relat Cancer,2009,16(4):1251-1260.
4Boelaert K,Horacek J,Holder RL,et al.Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration[J].J Clin Endocrinol Metab,2006,91(11):4295-4301.
5Haymart MR,Repplinger DJ,Leverson GE,et al.Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage[J].J Clin Endocrinol Metab,2008,93(3):809-814.
6Jo VY,Stelow EB,Dustin SM,et al.Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology[J].Am J Clin Pathol,2010,134(3):450-456.
7Bishop JA,Owens CL,Shum CH,et al.Thyroid bed fine-needle aspiration:experience at a large tertiary care center[J].Am J Clin Pathol,2010,134(2):335-339.
